Clinical Trial Update: Study to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe Hypertriglyceridemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of BIO89-100 (pegozafermin) in adults with severe hypertriglyceridemia has completed and results were posted in Jul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertriglyceridemia

Drugs mentioned

• BIO89-100 (Pegozafermin) (pegozafermin)

Snippet

Sponsor: 89bio, Inc. | Conditions: Severe Hypertriglyceridemia | Phase 2 | Status: COMPLETED | Results posted: 2024-07-25